Biomarkers Market

Biomarkers Market Revenue Drivers, Growth Opportunities, Value Chain Analysis and Forecast Research Report Till 2024

“The global biomarkers market size is expected to value at USD 78.2 billion by 2024 at higher CAGR over the forecast period, providing numerous opportunities for market players to invest in research and development.”

The global Biomarkers Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview: The global biomarkers market size is expected to value at USD 78.2 billion by 2024. The market is subject to witness a substantial growth due to the growing adoption of the biomarkers in the drug discovery and development along with growing R&D expenditure. Biomarkers are considered as quantifiable molecular alterations that are implemented for the development of highly precise and efficient therapeutic targets.

Key Players:           

Roche Diagnostics Ltd. Abbott Laboratories, Inc. Agilent Technologies, Inc. Siemens Healthcare GmbH Epigenomics AG GE Healthcare Thermo Fisher Scientific, Inc. Bio-Rad Laboratories, Inc. Qiagen Johnson & Johnson Merck & Co., Inc.

Request free sample to get complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/biomarkers-market-size/request-sample Growth Drivers: Factors responsible for the robust market growth of biomarkers, in the recent years, include prevalence of oncology, neurology, and cardiology-related disorders across the globe. Globally, the biomarkers industry is predicted to grow at higher CAGR over the forecast period, providing numerous opportunities for market players to invest in research and development of the market.

The recent technological advancement coupled with the development of novel products and techniques such as biomarker based-diagnostics are expected to fuel the growth of biomarkers market over the forecast period. Additionally, introduction of advanced diagnostic methods along with higher precision and sensitivity are projected to drive market growth in the upcoming years.

Growing implementation of number of safety biomarkers and increasing approval rate by local and international authorities are predicted to foster market growth in the near future. Development of innovative products such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which are capable of detecting toxicity in the kidney and liver, is propelling market demand for biomarker, in the last few years.

Substantial increase in occurrence of infectious diseases coupled with favorable government initiatives to promote early use of various diagnostic platforms in the developing and developed economies are estimated to positively influence market performance of biomarkers. Recent funding for research & development of the early and timely diagnosis of asymptomatic disorders like hemoglobinopathies are stimulating market expansion, in the recent years.

Application Outlook:   

Diagnostic Drug Development Personalized Medicine

Disease Outlook:    

Oncology Cardiovascular disease Neurological disease Immunological disease

Regional Outlook: North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine & pharmaceutical sector, increase in the R&D funding for drug discovery and testing, the high patient awareness levels regarding the availability of enhanced diagnostics techniques, and existence of well-established healthcare infrastructure in the region.

Asia-Pacific region is predicted to hold major market share in the biomarkers market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with increasing target population, strong economic growth, declining cost of clinical trials, rising healthcare infrastructure activities, and significant investment by leading industry players considering potential growth opportunities in the region.

Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/

Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com

Global Headquarters

Asia Pacific

Million Insights

Million Insights

Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States

Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 1-408-610-2300 Email: sales@millioninsights.com

Phone: 91-20-65300184 Email: sales@millioninsights.com